Back
Credit Acceptance 10K Form
Buy
60
CACC
Credit Acceptance
Last Price:
439.74
Seasonality Move:
7.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-30 | 10Q | CACC/Credit Acceptance Quarterly |
2024-02-12 | 10K | CACC/Credit Acceptance Annual |
2023-10-30 | 10Q | CACC/Credit Acceptance Quarterly |
2023-08-01 | 10Q | CACC/Credit Acceptance Quarterly |
2023-05-01 | 10Q | CACC/Credit Acceptance Quarterly |
2023-02-10 | 10K | CACC/Credit Acceptance Annual |
Receive CACC News And Ratings
See the #1 stock for the next 7 days that we like better than CACC
CACC Financial Statistics
Sales & Book Value
Annual Sales: | $1.88B |
---|---|
Cash Flow: | $317.3M |
Price / Cash Flow: | 4.93 |
Annual Sales: | $135.94 |
Price / Book: | 3.3 |
Profitability
EPS (TTM): | 14.89000 |
---|---|
Net Income (TTM): | $189.6M |
Gross Margin: | $1.26B |
Return on Equity: | 11.41% |
Return on Assets: | 2.37% |
Credit Acceptance Earnings Forecast
Key Credit Acceptance Financial Ratios
- The Gross Profit Margin over the past 20 years for CACC is 67.16%.
- The Selling, General & Administrative Expenses for CACC have been equal to 9.52% of Gross Profit Margin.
- The Interest Expense is 29.90% of Operating Income.
- The Net Earning history of CACC is 15.22% of Total Revenues.
- Per Share Earnings over the last 32 years have been positive in 24 years.
Credit Acceptance Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Consumer Finance |
Sector: | Financials |
Current Symbol: | CACC |
CUSIP: | 225310 |
Website: | creditacceptance.com |
Debt
Debt-to-Equity Ratio: | 3.8 |
---|---|
Current Ratio: | 23.4 |
Quick Ratio: | 21.85 |
Price-to-Earnings
Trailing P/E Ratio: | 20.37 |
---|---|
Forward P/E Ratio: | 12.48 |
CACC Technical Analysis vs Fundamental Analysis
Buy
60
Credit Acceptance (CACC)
is a Buy
Is Credit Acceptance a Buy or a Sell?
-
Credit Acceptance stock is rated a Buy
The current Credit Acceptance [CACC] share price is $448.00. The Score for CACC is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.